Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Artificial Intelligence That Predicts Sensitizing Potential of Cosmetic Ingredients with Accuracy Comparable to Animal and In Vitro Tests-How Does the Infotechnomics Compare to Other "Omics" in the Cosmetics Safety Assessment?

Tytuł:
Artificial Intelligence That Predicts Sensitizing Potential of Cosmetic Ingredients with Accuracy Comparable to Animal and In Vitro Tests-How Does the Infotechnomics Compare to Other "Omics" in the Cosmetics Safety Assessment?
Autorzy:
Kalicińska J; Department of Experimental Dermatology and Cosmetology, Jagiellonian University Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.
Wiśniowska B; Department of Social Pharmacy, Jagiellonian University Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.
Polak S; Department of Social Pharmacy, Jagiellonian University Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.
Spiewak R; Department of Experimental Dermatology and Cosmetology, Jagiellonian University Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Apr 06; Vol. 24 (7). Date of Electronic Publication: 2023 Apr 06.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, [2000-
MeSH Terms:
Artificial Intelligence*
Cosmetics*/adverse effects
Cosmetics*/chemistry
Animals ; Bayes Theorem ; Computer Simulation ; In Vitro Techniques ; Haptens ; Consumer Product Safety
References:
J Dermatol. 2012 Aug;39(8):677-81. (PMID: 22548403)
Toxicol In Vitro. 2015 Aug;29(5):901-16. (PMID: 25820135)
Australas J Dermatol. 2013 Feb;54(1):31-5. (PMID: 23083503)
Contact Dermatitis. 2017 Jul;77(1):42-48. (PMID: 28425114)
Toxicol In Vitro. 2011 Sep;25(6):1162-8. (PMID: 21669280)
Acta Derm Venereol. 2016 Feb;96(2):237-40. (PMID: 26259136)
Contact Dermatitis. 2005 Jun;52(6):329-32. (PMID: 15932584)
J Allergy Clin Immunol. 2014 Aug;134(2):362-72. (PMID: 24768652)
J Dermatol. 2005 Dec;32(12):951-5. (PMID: 16471456)
Contact Dermatitis. 2014 Apr;70(4):233-7. (PMID: 24372565)
Contact Dermatitis. 2014 Mar;70(3):187-9. (PMID: 24588374)
Br J Dermatol. 2003 Feb;148(2):259-64. (PMID: 12588377)
Contact Dermatitis. 2010 Nov;63(5):254-61. (PMID: 20731693)
Contact Dermatitis. 2015 May;72(5):297-304. (PMID: 25600880)
Contact Dermatitis. 2002 Mar;46(3):141-4. (PMID: 12000321)
Acta Derm Venereol. 1992 Nov;72(6):456-60. (PMID: 1362844)
J Pharm Biomed Anal. 2020 Jun 5;185:113199. (PMID: 32146287)
Br J Dermatol. 2016 Feb;174(2):319-29. (PMID: 26370659)
Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33474-33485. (PMID: 33318199)
Contact Dermatitis. 2021 Feb;84(2):82-94. (PMID: 32845019)
Contact Dermatitis. 2017 Jan;76(1):49-50. (PMID: 27957752)
Ann Dermatol Venereol. 2021 Jun;148(2):77-93. (PMID: 33642039)
Contact Dermatitis. 2016 Nov;75(5):265-275. (PMID: 27633650)
Med Pr. 2015;66(3):327-32. (PMID: 26325045)
J Eur Acad Dermatol Venereol. 2008 Nov;22(10):1227-31. (PMID: 18482316)
JAMA Dermatol. 2023 Mar 1;159(3):267-274. (PMID: 36652228)
Contact Dermatitis. 2005 Apr;52(4):216-25. (PMID: 15859994)
Contact Dermatitis. 2011 Jul;65(1):28-33. (PMID: 21309787)
Acta Derm Venereol. 2000 Jul-Aug;80(4):256-62. (PMID: 11028857)
Br J Dermatol. 2009 Nov;161(5):1124-9. (PMID: 19857210)
Contact Dermatitis. 2023 Feb;88(2):87-92. (PMID: 36443008)
Contact Dermatitis. 2016 Apr;74(4):230-5. (PMID: 26948414)
Int J Dermatol. 1999 Mar;38(3):181-6. (PMID: 10208612)
Contact Dermatitis. 1999 Nov;41(5):241-50. (PMID: 10554056)
Contact Dermatitis. 2004 Jul;51(1):13-9. (PMID: 15291826)
Contact Dermatitis. 2010 Feb;62(2):102-8. (PMID: 20136893)
Allergy. 2001 Dec;56(12):1192-6. (PMID: 11736749)
Contact Dermatitis. 2010 Aug;63(2):77-84. (PMID: 20573166)
Contact Dermatitis. 1986 May;14(5):271-4. (PMID: 3743036)
Contact Dermatitis. 1994 May;30(5):276-9. (PMID: 8088140)
Contact Dermatitis. 2013 May;68(5):307-13. (PMID: 23601065)
J Appl Toxicol. 2013 Nov;33(11):1337-52. (PMID: 23576290)
J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1071-81. (PMID: 25288472)
Br J Dermatol. 1998 Mar;138(3):467-76. (PMID: 9580801)
Contact Dermatitis. 2011 Nov;65(5):266-75. (PMID: 21943251)
Molecules. 2021 Jun 07;26(11):. (PMID: 34200462)
An Bras Dermatol. 2015 Sep-Oct;90(5):671-83. (PMID: 26560213)
Toxicol In Vitro. 2015 Feb;29(1):259-70. (PMID: 25448812)
Int J Dermatol. 2016 Jul;55(7):e386-91. (PMID: 26547761)
Regul Toxicol Pharmacol. 2015 Mar;71(2):337-51. (PMID: 25541156)
Contact Dermatitis. 2001 Jun;44(6):344-6. (PMID: 11380544)
Contact Dermatitis. 2015 Mar;72(3):164-71. (PMID: 25545830)
Br J Dermatol. 2011 Jun;164(6):1316-25. (PMID: 21332463)
Toxicol In Vitro. 2014 Dec;28(8):1482-97. (PMID: 25172300)
Contact Dermatitis. 2007 Sep;57(3):165-8. (PMID: 17680865)
Contact Dermatitis. 2005 Jan;52(1):39-43. (PMID: 15701129)
J Am Acad Dermatol. 2014 Jan;70(1):102-7. (PMID: 24220722)
Contact Dermatitis. 1998 Mar;38(3):127-31. (PMID: 9536402)
Contact Dermatitis. 1999 Oct;41(4):193-7. (PMID: 10515097)
Toxicol Res (Camb). 2017 Jun 13;6(5):595-610. (PMID: 30090528)
Contact Dermatitis. 2010 Nov;63(5):262-9. (PMID: 20946454)
Contact Dermatitis. 2007 Jan;56(1):10-5. (PMID: 17177703)
Methods. 2007 Jan;41(1):48-53. (PMID: 17161301)
Br J Dermatol. 2012 Jun;166 Suppl 2:16-9. (PMID: 22670614)
Contact Dermatitis. 2005 Dec;53(6):320-3. (PMID: 16364118)
Toxicol In Vitro. 2011 Apr;25(3):733-44. (PMID: 21195160)
Contact Dermatitis. 2010 Jun;62(6):371-2. (PMID: 20557344)
Arch Dermatol. 2008 Jan;144(1):67-72. (PMID: 18209170)
ALTEX. 2011;28(1):50-5. (PMID: 21311850)
Contact Dermatitis. 2014 Dec;71(6):348-55. (PMID: 25041423)
Clin Exp Allergy. 2007 Dec;37(12):1848-53. (PMID: 17941916)
Acta Dermatovenerol Alp Pannonica Adriat. 2008 Jun;17(2):61-8. (PMID: 18709291)
J Comput Chem. 2011 May;32(7):1466-74. (PMID: 21425294)
Clin Rev Allergy Immunol. 2019 Feb;56(1):110-118. (PMID: 30269296)
Contact Dermatitis. 2005 Apr;52(4):207-15. (PMID: 15859993)
Acta Derm Venereol. 2001 Jan-Feb;81(1):31-4. (PMID: 11411911)
Am J Contact Dermat. 1996 Jun;7(2):77-83. (PMID: 8796746)
Med Pr. 2006;57(5):431-7. (PMID: 17340985)
J Am Acad Dermatol. 2010 Nov;63(5):789-98. (PMID: 20643495)
Contact Dermatitis. 2007 Jul;57(1):1-10. (PMID: 17577350)
An Bras Dermatol. 2020 Nov - Dec;95(6):696-701. (PMID: 33036810)
Contact Dermatitis. 2015 Oct;73(4):195-221. (PMID: 26179009)
Contact Dermatitis. 2014 Jul;71(1):13-20. (PMID: 24645637)
J Cosmet Dermatol. 2014 Mar;13(1):68-71. (PMID: 24641608)
Grant Information:
N42/DBS/000108 Jagiellonian University Medical College
Contributed Indexing:
Keywords: contact allergy; cosmetic ingredients; in silico modelling; infotechnomics; risk assessment; sensitizing potential
Substance Nomenclature:
0 (Cosmetics)
0 (Haptens)
Entry Date(s):
Date Created: 20230413 Date Completed: 20230414 Latest Revision: 20230415
Update Code:
20240105
PubMed Central ID:
PMC10094956
DOI:
10.3390/ijms24076801
PMID:
37047774
Czasopismo naukowe
The aim of the current study was to develop an in silico model to predict the sensitizing potential of cosmetic ingredients based on their physicochemical characteristics and to compare the predictions with historical animal data and results from "omics"-based in vitro studies. An in silico model was developed with the use of WEKA machine learning software fed with physicochemical and structural descriptors of haptens and trained with data from published epidemiological studies compiled into estimated odds ratio (eOR) and estimated attributable risk (eAR) indices. The outcome classification was compared to the results of animal studies and in vitro tests. Of all the models tested, the best results were obtained for the Naive Bayes classifier trained with 24 physicochemical descriptors and eAR, which yielded an accuracy of 86%, sensitivity of 80%, and specificity of 90%. This model was subsequently used to predict the sensitizing potential of 15 emerging and less-studied haptens, of which 7 were classified as sensitizers: cyclamen aldehyde, N,N-dimethylacrylamide, dimethylthiocarbamyl benzothiazole sulphide, geraniol hydroperoxide, isobornyl acrylate, neral, and prenyl caffeate. The best-performing model (NaiveBayes eAR, 24 parameters), along with an alternative model based on eOR (Random Comittee eOR, 17 parameters), are available for further tests by interested readers. In conclusion, the proposed infotechnomics approach allows for a prediction of the sensitizing potential of cosmetic ingredients (and possibly also other haptens) with accuracy comparable to historical animal tests and in vitro tests used nowadays. In silico models consume little resources, are free of ethical concerns, and can provide results for multiple chemicals almost instantly; therefore, the proposed approach seems useful in the safety assessment of cosmetics.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies